Skip to main content Help with accessibility Skip to main navigation

SACUBITRIL/VALSARTAN film-coated tablets (Entresto®▼)

CCG Approval Status:

Date Added: 26 - Nov - 2020
Body System:
Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of SACUBITRIL/VALSARTAN film-coated tablets (Entresto®▼) for treating symptomatic chronic heart failure following specialist initiation and in accordance with NICE TA388.

North West Strategic Clinical Network and Senate

Position statement

Treatment algorithm

Patient information leaflet

GP communication letter

Static